CRSP

#1291
CRISPR Therapeutics AG
54.83 USD
+7.05%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
54.83
54.83
年范围
33.03
78.48
日变化
+7.05%
每月变动
+10.77%
6个月变化
-18.61%
年变化
+37.04%
前一天收盘价
51.22
开盘价
54.83
买价
卖价
最低价
54.83
High
54.83
交易量
99
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 5.26 B
  • Employee 393
  • Founded 2013
  • CEO Samarth Kulkarni
  • Website www.crisprtx.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-8.11
市销率
1 343.5

CRISPR Therapeutics AG

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023.

新闻